生物
免疫系统
癌症研究
效应器
免疫学
肿瘤微环境
表型
免疫疗法
癌症免疫疗法
白细胞介素21
白细胞介素12
免疫抑制
获得性免疫系统
自然杀伤细胞
转录因子
NK-92
Janus激酶3
电池类型
髓源性抑制细胞
髓样
细胞生物学
细胞
癌细胞
先天性淋巴细胞
淋巴因子激活杀伤细胞
免疫耐受
先天免疫系统
细胞因子
癌症
重编程
间质细胞
趋化因子
造血
T细胞
免疫分型
免疫检查点
作者
John R. Lozada,Atef Mir Ali,Christine Luo,Rosemary N. Plagens,Bin Zhang,Andrew Elliott,Ella Boytim,Nicholas A. Zorko,Elisabeth I. Heath,Akash Patnaik,Ari M. Vanderwalde,Emmanuel S. Antonarakis,Jeffrey S. Miller,Justin H. Hwang,Frank M. Cichocki
标识
DOI:10.1158/2326-6066.cir-25-1229
摘要
Natural killer (NK) cells represent key effectors of antitumor immunity, yet emerging evidence highlights populations with distinct roles in cancer. Despite such expanded diversity within the NK cell repertoire, we lack an understanding of how this heterogeneity affects immune responses and downstream clinical outcomes. Using single-cell RNA sequencing, we systematically profiled NK cells across cancer and uncovered a dichotomous phenotypic and functional landscape of tumor-infiltrating NK cells shaped by opposing intrinsic signaling programs that drive the expression of IFNG or TGFB1. These divergent programs are associated with distinct transcription factor circuits that integrate cues within the tumor microenvironment and skew NK cells toward proinflammatory or suppressive functions. We found that the capacity for NK cells to engage in either functional direction is intrinsically linked to their phenotypic identity. Canonical NK cells recruited from circulation predominantly directed suppressive TGFB1 signals toward effector CD8+ T cells in tumors. Of note, these subsets exhibited higher TGFB1 expression than intratumoral myeloid cells across tumor types. In contrast, a tissue-resident (TR) adaptive subset exhibited exclusively proinflammatory IFNG-driven profiles and was associated with prolonged survival in both primary and metastatic tumor settings. Moreover, these TR adaptive NK cells, but not other subsets, were linked to response to immune checkpoint blockade. Collectively, our study reveals a previously unrecognized regulatory axis in NK cells that shapes NK cell diversity and augments broader antitumor immune responses.
科研通智能强力驱动
Strongly Powered by AbleSci AI